EUVIMEDScopri EUVIMED
Open access · CC BY-NC-ND 4.0

TGFβ‐Mediated Overexpression of Podoplanin Serves as a Potential Diagnostic Biomarker in Acute Promyelocytic Leukemia

Akash Maity iD, Rohit Kumar, Madhavi Dutta, Ansit Mishra, Jitendra Gawde, Jagruti Patil, Darshana Kadam, Sumeet Mirgh iD, Anant Gokarn, Hasmukh Jain, Lingaraj Nayak, Bhausaheb Bagal and 6 more

Molecular Carcinogenesis · 2026

DOI: 10.1002/mc.70096 ↗

At a glance

Journal article in Molecular Carcinogenesis, 2026. Written by Akash Maity and 17 co-authors. Institution: Hasan Laboratory, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, Maharashtra, India. Major MEDLINE topics: Leukemia, Promyelocytic, Acute, Biomarkers, Tumor, Membrane Glycoproteins, Transforming Growth Factor beta. 28 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Indian Council of Medical Research, Department of Atomic Energy, Govt. of India.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Early diagnosis of acute promyelocytic leukemia (APL), driven by PML‐RARA oncoprotein, is vital for survival, as delays can cause fatal coagulopathy without prompt therapeutic intervention of all‐trans retinoic acid and arsenic trioxide. Although APL is diagnosed using microscopy, immunophenotyping, and FISH/PCR for PML‐RARA, morphological overlap with acute myeloid leukemia (AML) ‐M5 and AML‐M2 complicates identification. In resource‐limited settings, unavailability of real time ‐quantitiative PCR (RQ‐PCR) or delays in FISH/qualitative RT‐PCR results increase the risk of missed or late diagnosis with fatal outcomes. Podoplanin (PDPN), a glycoprotein overexpressed in APL cells, interacts with platelets to mediate thrombosis. We evaluated PDPN expression, regulation, and diagnostic potential in APL. PDPN mRNA (RQ‐PCR) and surface protein (flow cytometry) were significantly higher in APL than non‐APL AML ( p < 0.0001), consistent with TCGA‐LAML and BEATAML1.0 datasets. Sensitivity and specificity were 80.7% and 71.43% by RQ‐PCR, and 92.86% and 100% by flow cytometry, respectively. Chromatin immunoprecipitation followed by quantitative PCR (ChIP‐qPCR) and TGF‐ β1 stimulation confirmed SMAD binding and PDPN upregulation. Pharmacological inhibition of TGF‐β1 ligand using luspatercept reduced SMAD phosphorylation and PDPN expression, indicating TGF‐β/SMAD transcriptionally regulates PDPN. Additionally, ELISA‐based serum profiling showed significantly elevated TGF‐β1 levels in APL patients compared to non‐APL AML ( p < 0.0001). These findings identify PDPN overexpression as a downstream consequence of TGF‐β/SMAD signaling and highlight its potential as a diagnostic biomarker for APL.

Subjects

MeSH terms (MEDLINE)

Leukemia, Promyelocytic, AcuteBiomarkers, TumorMembrane GlycoproteinsTransforming Growth Factor betaHumansPodoplaninFemaleMaleMiddle AgedAdultSignal TransductionAgedCell Line, Tumor

Author keywords

RQ‐PCRTGF‐β1acute Promyelocytic Leukemia (APL)coagulopathyflow cytometrypodoplanin

Substances

PodoplaninPDPN protein, humanBiomarkers, TumorMembrane GlycoproteinsTransforming Growth Factor beta

Authors and institutions

  • Hasan Laboratory, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, Maharashtra, India.
  • Homi Bhabha National Institute (HBNI), Anushaktinagar, Mumbai, Maharashtra, India.
  • S.V.B. Cancer Research Laboratory, Mahamana Pandit Madanmohan Malaviya Cancer Centre (MPMMCC), Sundarpur, Varanasi, Uttar Pradesh, India.
  • Department of Statistics, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, Maharashtra, India.
  • Hematopathology Laboratory, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, Maharashtra, India.
  • Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, Maharashtra, India.

ORCID profiles: Akash Maity, Sumeet Mirgh, P G Subramanian

Funding

  • Indian Council of Medical Research
  • Department of Atomic Energy, Govt. of India

Cite

APA

Maity, A., Kumar, R., Dutta, M., Mishra, A., Gawde, J., Patil, J., Kadam, D., Mirgh, S., Gokarn, A., Jain, H., Nayak, L., Bagal, B., Punatar, S., Sengar, M., Khattry, N., Subramanian, P. G., Tembhare, P., & Hasan, S. K. (2026). TGFβ‐Mediated Overexpression of Podoplanin Serves as a Potential Diagnostic Biomarker in Acute Promyelocytic Leukemia. Molecular Carcinogenesis. https://doi.org/10.1002/mc.70096

Vancouver

Maity A, Kumar R, Dutta M, Mishra A, Gawde J, Patil J, et al. TGFβ‐Mediated Overexpression of Podoplanin Serves as a Potential Diagnostic Biomarker in Acute Promyelocytic Leukemia. Molecular Carcinogenesis. 2026. doi:10.1002/mc.70096

BibTeX
@article{Maity2026,
  author = {Maity, Akash and Kumar, Rohit and Dutta, Madhavi and Mishra, Ansit and Gawde, Jitendra and Patil, Jagruti and Kadam, Darshana and Mirgh, Sumeet and Gokarn, Anant and Jain, Hasmukh and Nayak, Lingaraj and Bagal, Bhausaheb and Punatar, Sachin and Sengar, Manju and Khattry, Navin and Subramanian, P G and Tembhare, Prashant and Hasan, Syed K},
  title = {TGFβ‐Mediated Overexpression of Podoplanin Serves as a Potential Diagnostic Biomarker in Acute Promyelocytic Leukemia},
  journal = {Molecular Carcinogenesis},
  year = {2026},
  doi = {10.1002/mc.70096}
}
Start for free →